Navigation Links
WX Crowned 'Chemistry CRO of the Year' by Pfizer
Date:4/4/2008

SHANGHAI, China, April 4, 2008 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it was awarded the 2007 Chemistry CRO of the Year Award by the Pfizer Chemistry Sourcing Center of Emphasis (CoE).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Richard Connell, Head of the Chemistry Sourcing CoE, presented the award plaque to Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, at a recent Steering Committee meeting held in Groton, Connecticut. WuXi PharmaTech has enjoyed a close and cooperative relationship with Pfizer for many years, with collaborations ranging from synthetic chemistry, parallel medicinal chemistry (PMC), and ADME to bioanalytical services. The award recognizes in particular the outstanding collaboration of the WuXi and Pfizer teams in an effort to shorten the cycle times between requests for and delivery of parallel medicinal chemistry.

Pfizer's Centers of Emphasis state their mission as "Delivering Value Through Partnership." The success of their partnership with WuXi was certainly reflected in this year's presentation of their Top Chemistry CRO Award.

As the largest pharmaceutical, biotechnology and medical device contract research organization, WuXi collaborates with Pfizer in a number of drug discovery and development areas. Dr. Gonghua Pan of Pfizer, a key member of the collaboration, commented on the impact, "With WuXi's help, we reduced the average time from submitting the request to shipping of the finished product from 65 days in 2006 to 43 days in 2007, and at no increase in cost. This improvement reflects their own corporate commitment to continuous improvement - a commitment embedded in their slogan, 'we are determined to serve you better(R).'"

"We are very honored to receive this recognition from Pfizer, one of our largest customers for many years, and we really appreciate the trust and support Pfizer has given us. In order to better serve our customers we are building a global service and resource platform that has both small molecule and biologics capabilities covering early stage discovery to commercial manufacturing. By continuously improving our services and operation excellence, we will live up to our service creed 'We are determined to serve you better(R),'" commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.

About WuXi PharmaTech

WuXi PharmaTech, headquartered in Shanghai, China, is a leading global pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the U.S. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to pharmaceutical, biotechnology and medical device companies. Our services are designed to assist our global customers in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions. For more information, please visit: http://www.wuxipharmatech.com.

CONTACT:

Sherry Shao

WuXi PharmaTech Inc.

+86 (21) 5046-4002


'/>"/>
SOURCE WuXi PharmaTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative
2. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
3. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
4. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
5. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
6. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
7. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
8. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
11. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Morf Media Inc ... training platform on mobile devices, today released a new interactive Food and ... Devices. The course is essential for owners or operators of places of business ...
(Date:5/3/2016)... ... May 03, 2016 , ... Wearable Tech ... driven conferences, will take place on June 7-8, 2016, at the New York Academy ... on incorporating technology -- including AR/VR, machine learning, apps, robotics and AI -- throughout ...
(Date:5/2/2016)... , May 2, 2016 Q ... its technology partner Mannin Research Inc. will be attending ... which takes place from May 1-5, 2016 in ... be meeting with its vendors and research partners. The ... development goals and other collaborative opportunities for the MAN-01 ...
(Date:4/29/2016)... ... April 29, 2016 , ... Proove ... excited to announce the launch of the Proove Health Foundation . The ... education to promote the use of personalized medicine for tackling the nation’s most-pressing ...
Breaking Biology Technology:
(Date:3/2/2016)... http://www.researchandmarkets.com/research/wzwqtz/global_biometrics ... "Global Biometrics Market in Hospitality Sector 2016-2020" ... , , Global biometrics market in the ... of around 27%   --> ... addition of the  "Global Biometrics Market in ...
(Date:3/1/2016)... , March 1, 2016 ... the addition of the  "Global Biometric ...  report to their offering. --> ... addition of the  "Global Biometric Access ... to their offering. --> ...
(Date:3/1/2016)... NEW YORK and SAN FRANCISCO ... announced today between HYPR Corp. and BitGo, Inc. extends ... assets, cryptocurrency, identities and private keys. ... secures over $1 billion per month in digital assets ... a staggering figure for any startup. HYPR enables enterprises ...
Breaking Biology News(10 mins):